On June 17, 2025, Rapport Therapeutics, Inc. held its Annual Meeting where stockholders elected three directors and ratified the appointment of PricewaterhouseCoopers as the independent accounting firm for 2025, with over 31 million votes in favor for the directors. The firm received about 32.8 million votes for its ratification, indicating strong shareholder support.